Clinical Trials
5 trialsNCT03162562 2020-12-22
The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer
CanariaBio Inc.
Phase 1 Terminated
NCT00034138 2007-12-18
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma
Unither Pharmaceuticals
Phase 1/2 Terminated
NCT00034372 2007-12-18
Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
Unither Pharmaceuticals
Phase 2 Terminated
NCT00050375 2007-12-18
Clinical Trial for Ovarian Cancer (OvaRex®)
Unither Pharmaceuticals
Phase 3 Terminated
NCT00086632 2007-12-18
Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment
Unither Pharmaceuticals
Phase 2 Terminated